274 related articles for article (PubMed ID: 25961930)
1. Oncolytic reovirus induces intracellular redistribution of Ras to promote apoptosis and progeny virus release.
Garant KA; Shmulevitz M; Pan L; Daigle RM; Ahn DG; Gujar SA; Lee PW
Oncogene; 2016 Feb; 35(6):771-82. PubMed ID: 25961930
[TBL] [Abstract][Full Text] [Related]
2. Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release.
Marcato P; Shmulevitz M; Pan D; Stoltz D; Lee PW
Mol Ther; 2007 Aug; 15(8):1522-30. PubMed ID: 17457318
[TBL] [Abstract][Full Text] [Related]
3. Exploring host factors that impact reovirus replication, dissemination, and reovirus-induced cell death in cancer versus normal cells in culture.
Shmulevitz M; Lee PW
Methods Mol Biol; 2012; 797():163-76. PubMed ID: 21948476
[TBL] [Abstract][Full Text] [Related]
4. Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer.
Shmulevitz M; Marcato P; Lee PW
Oncogene; 2005 Nov; 24(52):7720-8. PubMed ID: 16299532
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic Ras promotes reovirus spread by suppressing IFN-beta production through negative regulation of RIG-I signaling.
Shmulevitz M; Pan LZ; Garant K; Pan D; Lee PW
Cancer Res; 2010 Jun; 70(12):4912-21. PubMed ID: 20501842
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the Most Oncolytic Reovirus Strain Confer Enhanced Cell Attachment, Transcription, and Single-Step Replication Kinetics.
Mohamed A; Smiley JR; Shmulevitz M
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776267
[TBL] [Abstract][Full Text] [Related]
7. Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection.
Norman KL; Hirasawa K; Yang AD; Shields MA; Lee PW
Proc Natl Acad Sci U S A; 2004 Jul; 101(30):11099-104. PubMed ID: 15263068
[TBL] [Abstract][Full Text] [Related]
8. Reovirus and tumor oncolysis.
Kim M; Chung YH; Johnston RN
J Microbiol; 2007 Jun; 45(3):187-92. PubMed ID: 17618222
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of reovirus-induced cell death and tissue injury: role of apoptosis and virus-induced perturbation of host-cell signaling and transcription factor activation.
Clarke P; Debiasi RL; Goody R; Hoyt CC; Richardson-Burns S; Tyler KL
Viral Immunol; 2005; 18(1):89-115. PubMed ID: 15802955
[TBL] [Abstract][Full Text] [Related]
10. Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants.
Mohamed A; Johnston RN; Shmulevitz M
Viruses; 2015 Dec; 7(12):6251-78. PubMed ID: 26633466
[TBL] [Abstract][Full Text] [Related]
11. PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer.
Thirukkumaran C; Shi ZQ; Thirukkumaran P; Luider J; Kopciuk K; Spurrell J; Elzinga K; Morris D
PLoS One; 2017; 12(1):e0168233. PubMed ID: 28099441
[TBL] [Abstract][Full Text] [Related]
12. Strategic Combinations: The Future of Oncolytic Virotherapy with Reovirus.
Zhao X; Chester C; Rajasekaran N; He Z; Kohrt HE
Mol Cancer Ther; 2016 May; 15(5):767-73. PubMed ID: 27197256
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic Viral Therapy Using Reovirus.
Thirukkumaran C; Morris DG
Methods Mol Biol; 2015; 1317():187-223. PubMed ID: 26072409
[TBL] [Abstract][Full Text] [Related]
14. The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.
Kim M; Williamson CT; Prudhomme J; Bebb DG; Riabowol K; Lee PW; Lees-Miller SP; Mori Y; Rahman MM; McFadden G; Johnston RN
Oncogene; 2010 Jul; 29(27):3990-6. PubMed ID: 20473328
[TBL] [Abstract][Full Text] [Related]
15. Noncanonical Cell Death Induction by Reassortant Reovirus.
RodrÃguez Stewart RM; Raghuram V; Berry JTL; Joshi GN; Mainou BA
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847857
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanoma.
Pandha HS; Heinemann L; Simpson GR; Melcher A; Prestwich R; Errington F; Coffey M; Harrington KJ; Morgan R
Clin Cancer Res; 2009 Oct; 15(19):6158-66. PubMed ID: 19773377
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic Reovirus Infection Is Facilitated by the Autophagic Machinery.
Kemp V; Dautzenberg IJC; Limpens RW; van den Wollenberg DJM; Hoeben RC
Viruses; 2017 Sep; 9(10):. PubMed ID: 28934149
[TBL] [Abstract][Full Text] [Related]
18. CUG2, a novel oncogene confers reoviral replication through Ras and p38 signaling pathway.
Park EH; Park EH; Cho IR; Srisuttee R; Min HJ; Oh MJ; Jeong YJ; Jhun BH; Johnston RN; Lee S; Koh SS; Chung YH
Cancer Gene Ther; 2010 May; 17(5):307-14. PubMed ID: 20075984
[TBL] [Abstract][Full Text] [Related]
19. Activation of p53 by chemotherapeutic agents enhances reovirus oncolysis.
Pan D; Marcato P; Ahn DG; Gujar S; Pan LZ; Shmulevitz M; Lee PW
PLoS One; 2013; 8(1):e54006. PubMed ID: 23342061
[TBL] [Abstract][Full Text] [Related]
20. Acquired resistance to reoviral oncolysis in Ras-transformed fibrosarcoma cells.
Kim M; Egan C; Alain T; Urbanski SJ; Lee PW; Forsyth PA; Johnston RN
Oncogene; 2007 Jun; 26(28):4124-34. PubMed ID: 17213803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
